Powder: -20°C for 3 years | In solvent: -80°C for 1 year
CCG-63802 is a reversible small-molecule inhibitor of regulator of G protein signaling (RGS) proteins. CCG-63802 inhibits the interaction between RGS4 and Galpha with an IC50 value of 1.4 μM.
パッケージサイズ | 在庫状況 | 単価(税別) |
---|---|---|
5 mg | 在庫あり | ¥ 13,000 |
10 mg | 在庫あり | ¥ 22,500 |
25 mg | 約6-8 週間 | ¥ 49,000 |
50 mg | 約6-8 週間 | ¥ 91,000 |
説明 | CCG-63802 is a reversible small-molecule inhibitor of regulator of G protein signaling (RGS) proteins. CCG-63802 inhibits the interaction between RGS4 and Galpha with an IC50 value of 1.4 μM. |
ターゲット&IC50 | RGS4:1.4 μM |
In vitro | CCG-63802 inhibits GTPase accelerating protein activity of RGS4 and blocks its interaction with Gαo. |
分子量 | 450.51 |
分子式 | C26H18N4O2S |
CAS No. | 620112-78-9 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 1.67 mg/mL (3.71 mM), Sonication and heating are recommended.
You can also refer to dose conversion for different animals. 詳細
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
CCG-63802 620112-78-9 GPCR/G Protein GTPase inflammation CCG 63802 RGS reversible selective Regulator of G-protein Signaling Regulators of G-protein Signaling inhibit CCG63802 Inhibitor RGS Protein inhibitor